Stock Events

Stock Events

Sonnet Biotherapeutics (SONN) Q3 2025 Earnings

16DecConfirmed

Q1 2025

Q2 2025

Q3 2025

Q3 2025

-1.56

-1.2

-0.85

-0.49

Details

Expected EPS

-0.49

Actual EPS

-0.79

Surprise EPS

-0.3

Surprise Percent

+61.22%

Description

Sonnet Biotherapeutics (SONN) has reported earnings of -0.79 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.